Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesCurrent DebtDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Non-Current Debt: 2009-2024

Historic Non-Current Debt for Fresenius Medical Care AG (FMS) over the last 7 years, with Q3 2021 value amounting to $427.3 million.

  • Fresenius Medical Care AG's Non-Current Debt fell 222.29% to $427.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $427.3 million, marking a year-over-year decrease of 222.29%. This contributed to the annual value of $413.7 million for FY2020, which is 126.32% down from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Non-Current Debt of $7.4 billion as of Q3 2025, which was up 796.03% from $7.2 billion recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Non-Current Debt ranged from a high of $8.4 billion in Q1 2022 and a low of $6.5 billion during Q1 2025
  • In the last 5 years, Fresenius Medical Care AG's Non-Current Debt had a median value of $7.6 billion in 2021 and averaged $7.5 billion.
  • Its Non-Current Debt has fluctuated over the past 5 years, first tumbled by 570.92% in 2019, then surged by 588.75% in 2021.
  • Quarter analysis of 4 years shows Fresenius Medical Care AG's Non-Current Debt stood at $439.2 million in 2018, then decreased by 5.71% to $414.2 million in 2019, then increased by 4.32% to $432.1 million in 2020, then dropped by 1.09% to $427.3 million in 2021.
  • Its last three reported values are $427.3 million in Q3 2021, $436.4 million for Q2 2021, and $437.1 million during Q1 2021.